Torrent Pharma Warned by US Again, This Time for Using Bacteria-Contaminated Water SystemNovember 22, 2019
Statement on New Testing Results, Including Low Levels of Impurities in Ranitidine DrugsNovember 5, 2019
FDA and DEA Warn Website Operators Illegally Selling Opioids – Drug Information UpdateSeptember 30, 2019
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USPApril 22, 2019
FDA Warns CanaRx for Selling Unapproved, Misbranded and Unsafe Imported Drugs to Unsuspecting AmericansApril 19, 2019
FDA Says Up to Two Million People Exposed to Likely Carcinogens in Blood-Pressure DrugsJanuary 28, 2019
Five additional countries to benefit from EU-US mutual recognition agreement for inspections | European Medicines AgencyJanuary 6, 2019
Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USPJanuary 4, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practiceDecember 13, 2018
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medicationsDecember 13, 2018
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugsNovember 19, 2018
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and HydrochlorothiazideNovember 14, 2018
Pfizer, Inc. Issues A Voluntary Nationwide Recall Of One Lot Of Children’s Advil® Suspension Bubble Gum Flavored 4 FL OZ BottleAugust 31, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA’s ongoing investigation into valsartan impurities and recalls and an update on FDA’s current findingsAugust 31, 2018
FDA Announces Voluntary Recall of Montelukast Tablets by Camber Pharmaceuticals Due to Incorrect Drug in BottlesAugust 31, 2018
Product Quest Manufacturing LLC Recalls All Nasal Products and Baby Oral Gels Manufactured at Florida Facility Due to Possible Microbial ContaminationAugust 29, 2018
URI Chemistry Professor Develops New Contaminant Detection Technique for Blood Thinner HeparinAugust 27, 2018
Over Half Of U.S. States Have Now Seen Fatalities From Counterfeit Drugs Made With FentanylAugust 23, 2018
FDA Alerts Drug Makers of a Recall of Porcine Thyroid API from Sichuan Friendly Pharmaceutical Co., Limited, ChinaAugust 20, 2018
Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ TabletsAugust 20, 2018
Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of AdulterationAugust 16, 2018
Proposed Changes To WHOIS System Privacy Will Help Hide Internet Criminals, NABP Director WarnsAugust 9, 2018
EMA Reviewing Medicines Containing Valsartan from Zhejiang Huahai Following Detection of an ImpurityAugust 9, 2018
FDA Waivers, Exceptions, and Exemptions from the Requirements of Section 582 of the Federal Food, Drug, and Cosmetic ActJune 22, 2018
Rx-360 Supplier Led Working Group Releases All Modules of Supplier Assessment Questionnaire Version 2.0May 2, 2018
